AdaptHealth (AHCO) Capital Expenditures Growth (3y) (2022 - 2026)
AdaptHealth (AHCO) Capital Expenditures Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 2.15% |
| 10 | AdaptHealth | 1.50 Bn | 1.45 Bn | 111.50 Mn | 43.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.15% |
| Dec 31, 2025 | 80.69% |
| Sep 30, 2025 | 42.78% |
| Jun 30, 2025 | 4.74% |
| Mar 31, 2025 | 7.40% |
| Dec 31, 2024 | -63.33% |
| Sep 30, 2024 | -22.44% |
| Jun 30, 2024 | 42.63% |
| Mar 31, 2024 | 5.73% |
| Dec 31, 2023 | -144.32% |
| Sep 30, 2023 | 69.45% |
| Jun 30, 2023 | 532.85% |
| Mar 31, 2023 | 66.76% |
| Dec 31, 2022 | -80.42% |
| Sep 30, 2022 | -210.29% |
| Jun 30, 2022 | 142.03% |
| Mar 31, 2022 | 144.22% |